Abstracts

SUSTAINED SEROPREVALENCE IN HEALTH CARE WORKERS AT A QUATERNARY CENTER, NEW YORK CITY

Health care workers (HCWs) remain disproportionately affected by COVID-19. They experience higher transmission rates of SARS-CoV-2, and the extent, duration and pattern of antibody response remains under examined. The correlates of serological patterns are also unclear. We examined longitudinal SARS-CoV-2 sero-patterns and their correlates among a cohort of HCW. HCWs (N=465) were recruited at a…

GLOBAL TRENDS IN PEDIATRIC ON-TREATMENT MORTALITY ADJUSTED FOR LOSS TO CARE BIASES

UNAIDS projections of pediatric HIV prevalence and deaths rely on the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium for mortality estimates among children with HIV (CHIV) receiving antiretroviral therapy (ART). Previous estimates may no longer be accurate due to expanded pediatric HIV care and treatment, and the possibility of unreported deaths in CHIV considered…

MORTALITY IN CHILDREN & YOUTH (

Despite significant progress in addressing HIV/AIDS, children, adolescents and young adults living with HIV (CAYHIV) continue to have poorer outcomes than adults aged ?25 years. Loss to follow up (LTF) in antiretroviral therapy (ART) programs is a major challenge to achieving optimal treatment outcomes and the UNAIDS 2030 target. We aimed to compare site-reported mortality…

MICROBIOLOGICAL FEATURES AND FOLLOW-UP OF NEONATES BORN TO MOTHERS WITH COVID-19

Literature evaluating the effect of SARS-CoV-2 infection in exposed newborns during pregnancy is still scarce. Although a 3% rate of perinatal transmission has been described, there is not enough evidence of viral transmission in biological samples through microbiological techniques. Our aim is to describe perinatal transmission in newborns exposed to SARS-CoV-2 during pregnancy and their…

SAFETY AND EFFICACY OF REMDESIVIR IN A PEDIATRIC COVID-19 POPULATION

COVID-19 is generally a mild disease in children and infants. However, a small proportion develop severe disease requiring intensive care and ventilatory support. Remdesivir (RDV), a direct-acting nucleotide pro-drug inhibitor of viral RNA-dependent RNA polymerases, has been shown to shorten time to recovery in adults with severe COVID-19. The aim of this study is to…